Natalia Eugene , Eric Li , Julianna Wolochuk , Courtney Lee , Zi Zhang
{"title":"Phyllodes tumor of the breast: Race-related differences in presentation, pathology and prognosis","authors":"Natalia Eugene , Eric Li , Julianna Wolochuk , Courtney Lee , Zi Zhang","doi":"10.1016/j.clinimag.2025.110544","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose</h3><div>We aimed to investigate the race-related differences in clinical, radiological, and pathological presentation and prognosis of phyllodes tumors (PTs).</div></div><div><h3>Methods</h3><div>This retrospective cohort study included patients diagnosed with PTs from 5/1/2012 to 5/31/2022. Pathology reports, radiology findings, and clinical data were extracted from electronic medical records. Statistical analysis assessed these differences across racial demographics.</div></div><div><h3>Results</h3><div>Among 62 women with PTs (mean age: 41 ± 15.2 years), the racial distribution was 21 % Caucasian, 32 % African American, 17.7 % Hispanic, and 29 % Asian/Other. Minority women were significantly more likely to present with palpable masses than Caucasian patients (<em>p</em> = 0.031), suggesting potential disparities in early detection. Minority patients were more likely to be covered by Medicaid and reside in lower-income ZIP codes, with a higher proportion under age 40 at presentation, though these results were not statistically significant. While tumor size varied by race, this difference was also not statistically significant (<em>p</em> = 0.094). Pathologically, 66.1 % of tumors were benign, 22.6 % borderline, and 11.3 % malignant. Although lumpectomy was the preferred approach across all racial groups, no Caucasian or Hispanic patients undergoing mastectomy. No significant racial differences were observed in resection margins (<em>p</em> = 0.263), re-excision rates (<em>p</em> = 0.503), or recurrence rates (<em>p</em> = 0.238).</div></div><div><h3>Conclusion</h3><div>Minority women had a higher likelihood of presenting with symptomatic PTs, underscoring potential disparities in screening. While treatment outcomes were similar across racial groups, targeted screening efforts in at-risk populations may improve early detection and promote equitable healthcare access.</div></div>","PeriodicalId":50680,"journal":{"name":"Clinical Imaging","volume":"125 ","pages":"Article 110544"},"PeriodicalIF":1.5000,"publicationDate":"2025-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Imaging","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0899707125001445","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose
We aimed to investigate the race-related differences in clinical, radiological, and pathological presentation and prognosis of phyllodes tumors (PTs).
Methods
This retrospective cohort study included patients diagnosed with PTs from 5/1/2012 to 5/31/2022. Pathology reports, radiology findings, and clinical data were extracted from electronic medical records. Statistical analysis assessed these differences across racial demographics.
Results
Among 62 women with PTs (mean age: 41 ± 15.2 years), the racial distribution was 21 % Caucasian, 32 % African American, 17.7 % Hispanic, and 29 % Asian/Other. Minority women were significantly more likely to present with palpable masses than Caucasian patients (p = 0.031), suggesting potential disparities in early detection. Minority patients were more likely to be covered by Medicaid and reside in lower-income ZIP codes, with a higher proportion under age 40 at presentation, though these results were not statistically significant. While tumor size varied by race, this difference was also not statistically significant (p = 0.094). Pathologically, 66.1 % of tumors were benign, 22.6 % borderline, and 11.3 % malignant. Although lumpectomy was the preferred approach across all racial groups, no Caucasian or Hispanic patients undergoing mastectomy. No significant racial differences were observed in resection margins (p = 0.263), re-excision rates (p = 0.503), or recurrence rates (p = 0.238).
Conclusion
Minority women had a higher likelihood of presenting with symptomatic PTs, underscoring potential disparities in screening. While treatment outcomes were similar across racial groups, targeted screening efforts in at-risk populations may improve early detection and promote equitable healthcare access.
期刊介绍:
The mission of Clinical Imaging is to publish, in a timely manner, the very best radiology research from the United States and around the world with special attention to the impact of medical imaging on patient care. The journal''s publications cover all imaging modalities, radiology issues related to patients, policy and practice improvements, and clinically-oriented imaging physics and informatics. The journal is a valuable resource for practicing radiologists, radiologists-in-training and other clinicians with an interest in imaging. Papers are carefully peer-reviewed and selected by our experienced subject editors who are leading experts spanning the range of imaging sub-specialties, which include:
-Body Imaging-
Breast Imaging-
Cardiothoracic Imaging-
Imaging Physics and Informatics-
Molecular Imaging and Nuclear Medicine-
Musculoskeletal and Emergency Imaging-
Neuroradiology-
Practice, Policy & Education-
Pediatric Imaging-
Vascular and Interventional Radiology